CAH Cardinal Health, Inc.
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Company profile
Ticker
CAH
Exchange
Website
CEO
Michael C. Kaufmann
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
McKesson • Amerisourcebergen • Herbalife Nutrition • Nu Skin Enterprises • PetIQ • Merion • Trxade • Cosmos • Can B • Lepota ...
Former names
Cardinal Distribution Inc
SEC CIK
Corporate docs
IRS number
310958666
CAH stock data
()
Calendar
11 May 20
3 Jul 20
30 Jun 21
News
Company financial data Financial data
| Quarter (USD) | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | 39.16B | 39.74B | 37.34B | 37.35B | |
| Net income | 351M | 220M | -4.92B | 194M | |
| Net profit margin | 0.90% | 0.55% | -13.18% | 0.52% | |
| Operating income | 562M | 334M | -5.26B | 308M | |
| Net change in cash | 670M | 447M | -1.32B | -907M | |
| Cash on hand | 2.33B | 1.66B | 1.21B | 2.53B | |
| Cost of revenue | 37.27B | 38.02B | 35.66B | 35.68B |
| Annual (USD) | Jun 19 | Jun 18 | Jun 17 | Jun 16 | |
|---|---|---|---|---|---|
| Revenue | 145.53B | 136.81B | 129.98B | 121.55B | |
| Net income | 1.37B | 259M | 1.29B | 1.43B | |
| Diluted EPS | |||||
| Net profit margin | 0.94% | 0.19% | 1.00% | 1.18% | |
| Operating income | 2.06B | 126M | 2.12B | 2.46B | |
| Net change in cash | 768M | -5.12B | 4.52B | -2.26B | |
| Cash on hand | 2.53B | 1.76B | 6.88B | 2.36B | |
| Cost of revenue | 138.7B | 129.63B | 123.43B | 115B |
Financial data from company earnings reports
Recent insider trades
| Date | Owner | Security | Transaction | Code | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|
| 28 Jun 20 | Kaufmann Michael C | Common Shares | Payment of exercise | Dispose F | 50.55 | 6,649 | 336.11K | 403,762 |
| 15 Apr 20 | Scarborough Dean A | Phantom Stock Common Shares | Grant | Aquire A | 50.69 | 567 | 28.74K | 1,564 |
| 15 Apr 20 | J Michael Losh | Phantom Stock Common Shares | Grant | Aquire A | 50.69 | 690 | 34.98K | 4,405 |
| 15 Mar 20 | Mayer Jessica L | Common Shares | Payment of exercise | Dispose F | 47.62 | 916 | 43.62K | 48,009 |
Institutional ownership Q1 2020
84.3% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 699 |
| Opened positions | 99 |
| Closed positions | 92 |
| Increased positions | 240 |
| Reduced positions | 258 |
13F shares |
Current |
|---|---|
| Total value | 11.82B |
| Total shares | 246.24M |
| Total puts | 2.12M |
| Total calls | 1.25M |
| Total put/call ratio | 1.7 |
Largest owners |
Shares | Value |
|---|---|---|
| Vanguard | 36.6M | $1.75B |
| BLK BlackRock | 23.02M | $1.1B |
| STT State Street | 20M | $968.17M |
| MCQEF Macquarie | 13.72M | $657.93M |
| N Price T Rowe Associates | 8.31M | $398.53M |
| BK Bank Of New York Mellon | 6.88M | $329.6M |
| FMR | 6.75M | $323.52M |
| Geode Capital Management | 5.02M | $240.6M |
| AIG American International | 4.85M | $232.52M |
| IVZ Invesco | 4.63M | $221.95M |
Financial report summary
?Competition
Owens & Minor • Ssi Surgical Services • Respironics • Cima Labs • Positron • Merit Medical Systems • Alpha Pro Tech • Allergan Finance • Omnicell • McKesson
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
amplify, approach, Cabell, Cherokee, collaboration, Confidentiality, curtailing, cyber, deferral, demand, distancing, dramatically, duration, economy, environment, experienced, export, face, found, Francisco, hardship, heighten, Hollar, Huntington, India, instituted, Jason, lesser, local, modest, outbreak, pandemic, player, PPE, raw, remanded, resume, San, scope, situation, social, strain, transmission, vendor, Virginia, volume, West
Removed:
accounted, arrive, declared, decline, dispensing, failure, favorably, fourth, influence, prescribing, reflected, unanticipated
Financial reports
10-Q
2020 Q3
Quarterly report
11 May 20
10-Q
2020 Q2
Quarterly report
6 Feb 20
10-Q
2020 Q1
Quarterly report
7 Nov 19
10-K
2019 FY
Annual report
20 Aug 19
10-Q
2019 Q3
Quarterly report
9 May 19
10-Q
2019 Q2
Quarterly report
7 Feb 19
10-Q
2019 Q1
Quarterly report
8 Nov 18
10-K
2018 FY
Annual report
22 Aug 18
10-Q
2018 Q3
Quarterly report
9 May 18
10-Q
2018 Q2
Quarterly report
8 Feb 18
Current reports
8-K
Departure of Directors or Certain Officers
26 Jun 20
8-K
Cardinal Health Reports Third Quarter Results for Fiscal Year 2020
11 May 20
8-K
Cardinal Health names Jason Hollar as new Chief Financial Officer
19 Mar 20
8-K
Cardinal Health Reports Second Quarter Results for Fiscal Year 2020
6 Feb 20
8-K
Cardinal Health announces voluntary field actions for select procedure packs containing affected surgical gowns
30 Jan 20
8-K
Departure of Directors or Certain Officers
24 Jan 20
8-K
Amendments to Articles of Incorporation or Bylaws
12 Nov 19
8-K
Cardinal Health Reports First Quarter Results for Fiscal Year 2020
7 Nov 19
8-K
Entry into a Material Definitive Agreement
2 Oct 19
8-K
Departure of Directors or Certain Officers
8 Aug 19
Registration and prospectus
S-8
Registration of securities for employees
20 Aug 19
S-3ASR
Automatic shelf registration
20 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Aug 17
S-8
Registration of securities for employees
10 Aug 17
424B2
Prospectus for primary offering
5 Jun 17
FWP
Free writing prospectus
2 Jun 17
424B2
Prospectus for primary offering
1 Jun 17
S-3ASR
Automatic shelf registration
7 Feb 17
Proxies
PX14A6G
Letter to shareholders
4 Nov 19
PX14A6G
Letter to shareholders
4 Oct 19
DEFA14A
Additional proxy soliciting materials
20 Sep 19
DEF 14A
Definitive proxy
20 Sep 19
PX14A6G
Letter to shareholders
18 Oct 18
DEFA14A
Additional proxy soliciting materials
26 Sep 18
DEF 14A
Definitive proxy
26 Sep 18
PX14A6G
Letter to shareholders
8 Nov 17
PX14A6G
Letter to shareholders
7 Nov 17
DEFA14A
Additional proxy soliciting materials
6 Nov 17
Other
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
30 May 19
SD
Conflict minerals disclosure
30 May 18
NO ACT
No action letter
8 Sep 17
NO ACT
No action letter
4 Aug 17
NO ACT
No action letter
3 Aug 17
SD
Conflict minerals disclosure
31 May 17
NO ACT
No action letter
20 Jul 16
SD
Conflict minerals disclosure
31 May 16
SD
Conflict minerals disclosure
29 May 15
Ownership
4
CARDINAL HEALTH / Michael C Kaufmann ownership change
30 Jun 20
3
CARDINAL HEALTH / Jason M. Hollar ownership change
1 Jun 20
4
CARDINAL HEALTH / DEAN A SCARBOROUGH ownership change
16 Apr 20
4
CARDINAL HEALTH / J MICHAEL LOSH ownership change
16 Apr 20
4
CARDINAL HEALTH / Jessica L Mayer ownership change
17 Mar 20
4
CARDINAL HEALTH / Brian S Rice ownership change
18 Feb 20
SC 13G
Beneficial ownership report
13 Feb 20
SC 13G
Cardinal Health Inc
13 Feb 20
SC 13G/A
Beneficial ownership report (amended)
11 Feb 20
SC 13G/A
Cardinal Health Inc
5 Feb 20